Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

invictusoncology.com

Stage

Series A - II | Alive

Total Raised

$1.88M

About Invictus Oncology

Invictus Oncology is devoted to improving the lives of cancer patients by developing an anti-cancer drug. The company aims to develop platinum chemotherapies used in the treatment of different types of cancer, including lung, testicular, colorectal and childhood cancers.

Invictus Oncology Headquarters Location

465 Patparganj Industrial Area I Floor

New Delhi, 110092,

India

+91-11-4053 2833

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Invictus Oncology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Invictus Oncology is included in 2 Expert Collections, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Invictus Oncology Patents

Invictus Oncology has filed 8 patents.

The 3 most popular patent topics include:

  • Experimental cancer drugs
  • Oncology
  • Antineoplastic drugs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/11/2017

8/11/2020

Clusters of differentiation, Experimental cancer drugs, Transcription factors, Immunology, Oncology

Grant

Application Date

2/11/2017

Grant Date

8/11/2020

Title

Related Topics

Clusters of differentiation, Experimental cancer drugs, Transcription factors, Immunology, Oncology

Status

Grant

Latest Invictus Oncology News

Invictus Oncology Pvt Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250

Oct 31, 2018

Invictus Oncology Pvt Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250 14:14 EDT 31 Oct 2018 | BioPortfolio Reports Summary Invictus Oncology Pvt Ltd Invictus Oncology is a biopharmaceutical company with focus on the discovery, development and commercialization of anticancer drugs. The company develops platinumbased drugs to treat various types of cancers. It engineers platinumbased drugs harnessing structure activity relationships for increased efficiency and reduced side effects. Invictus Oncology is also developing a portfolio of antibody drug conjugates ADCs based on its proprietary linker chemistry for tumorspecific delivery of the drug, without damaging healthy tissues. The company works in collaboration with academics, universities, industry and hospitals to develop innovative cancer treatments. It has partnership with India Innovation Research Center. The company is funded by Navam Capital and Aarin Capital. Invictus Oncology is headquartered in Delhi, India. Invictus Oncology Pvt Ltd Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

  • Where is Invictus Oncology's headquarters?

    Invictus Oncology's headquarters is located at 465 Patparganj Industrial Area, New Delhi.

  • What is Invictus Oncology's latest funding round?

    Invictus Oncology's latest funding round is Series A - II.

  • How much did Invictus Oncology raise?

    Invictus Oncology raised a total of $1.88M.

  • Who are the investors of Invictus Oncology?

    Investors of Invictus Oncology include Ratan Tata, Aarin Capital and Navam Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.